CIK 0001850902
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Alpha Teknova, Inc.
Sign in to watch- Ticker
- TKNO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943368109
- Phone
- +1 831-637-1100
- Business address
- 2451 BERT DRIVE, HOLLISTER, CA, 95023
- 4 Open-market buy President and CEO bought 80,645 shares at $1.24 ($100,000)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Open-market buy Director bought 9,212 shares at an average $5.37 ($49,504)
- 4 Grant or award Director acquired 18,815 shares (grant or award)
- 4 Grant or award Director acquired 18,815 shares (grant or award)
- 4 Grant or award Director acquired 18,815 shares (grant or award)
- 4 Open-market buy Chief Commercial Officer bought 3,587 shares at $1.73 ($6,220)
- 4 Other disposition Chief People Officer disposed of 15,000 shares (other)
- 4 Open-market buy 10% owner bought 8,108,107 shares at $1.85 ($14,999,998)
- 4 Open-market buy General Counsel and CCO bought 27,027 shares at $1.85 ($50,000)
- 4 Open-market buy Director bought 810,810 shares at $1.85 ($1,499,999)
- 4 Open-market buy Chief Financial Officer bought 54,054 shares at $1.85 ($100,000)
- 4 Open-market buy President and CEO bought 54,054 shares at $1.85 ($100,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief People Officer sold 11,400 shares at $3.80 ($43,268)
- 4 Open-market buy Director bought 2,000 shares at an average $3.22 ($6,430)
- 4 Open-market buy Director bought 2,000 shares at an average $3.22 ($6,430)
Page 2 of 5 · 93 filings